Stem cell engineering approaches for investigating glial cues in central nervous system disorders

Glial cells are important in maintaining homeostasis for neurons in the central nervous system (CNS). During CNS disease or after injury, glia react to altered microenvironments and often acquire altered functions that contribute to disease pathology. A major focus for research is utilizing stem cel...

Full description

Saved in:
Bibliographic Details
Published in:Current opinion in biotechnology 2024-06, Vol.87, p.103131, Article 103131
Main Authors: Vardhan, Sangamithra, Jordan, Tyler, Sakiyama-Elbert, Shelly
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c311t-182fb866c148bf28f3704cbed9dfc68049507e652eef8aa188036587fda5c3d73
container_end_page
container_issue
container_start_page 103131
container_title Current opinion in biotechnology
container_volume 87
creator Vardhan, Sangamithra
Jordan, Tyler
Sakiyama-Elbert, Shelly
description Glial cells are important in maintaining homeostasis for neurons in the central nervous system (CNS). During CNS disease or after injury, glia react to altered microenvironments and often acquire altered functions that contribute to disease pathology. A major focus for research is utilizing stem cell (SC)-derived glia as a potential renewable source for cell replacement to restore function, including neuronal support, and as a model for disease states to identify therapeutic targets. In this review, we focus on SC differentiation protocols for deriving three types of glial cells, astrocytes, oligodendrocytes, and microglia. These SC-derived glia can be used to identify critical cues that contribute to CNS disease progression and aid in investigation of therapeutic targets. [Display omitted] •Embryonic stem cell-derived glia cell types.•Protocols to generate glia in vitro.•Glial-derived cues playing roles in CNS disease progression.•Glial-derived CNS therapies.
doi_str_mv 10.1016/j.copbio.2024.103131
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3037399059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0958166924000673</els_id><sourcerecordid>3037399059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-182fb866c148bf28f3704cbed9dfc68049507e652eef8aa188036587fda5c3d73</originalsourceid><addsrcrecordid>eNp9UMtOwzAQtBCIlsIfIJQjlxQ7zsO-IKGKl1SJA3C2HHsdXCVOsdNK_XscpXDktNrdmd2ZQeia4CXBpLzbLFW_rW2_zHCWxxEllJygOWEVT3Ge8VM0x7xgKSlLPkMXIWwwxgWt8DmaUVZwjkk2R_J9gC5R0LYJuMY6AG9dk8jt1vdSfUFITO8T6_YQBtvIYVw2rZVtonZxaV3kusHH3oHf97uQhEMYT2obeq_Bh0t0ZmQb4OpYF-jz6fFj9ZKu355fVw_rVFFChpSwzNSsLBXJWW0yZqLSXNWguTaqZDjnBa6gLDIAw6QkjGFaFqwyWhaK6oou0O10Nyr_jtoG0dkwGpMOoi5BMa1odF3wCM0nqPJ9CB6M2HrbSX8QBIsxXLERU7hiDFdM4UbazfHDru5A_5F-04yA-wkA0efeghdBWXAKtPWgBqF7-_-HHzKjjj0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3037399059</pqid></control><display><type>article</type><title>Stem cell engineering approaches for investigating glial cues in central nervous system disorders</title><source>Elsevier</source><creator>Vardhan, Sangamithra ; Jordan, Tyler ; Sakiyama-Elbert, Shelly</creator><creatorcontrib>Vardhan, Sangamithra ; Jordan, Tyler ; Sakiyama-Elbert, Shelly</creatorcontrib><description>Glial cells are important in maintaining homeostasis for neurons in the central nervous system (CNS). During CNS disease or after injury, glia react to altered microenvironments and often acquire altered functions that contribute to disease pathology. A major focus for research is utilizing stem cell (SC)-derived glia as a potential renewable source for cell replacement to restore function, including neuronal support, and as a model for disease states to identify therapeutic targets. In this review, we focus on SC differentiation protocols for deriving three types of glial cells, astrocytes, oligodendrocytes, and microglia. These SC-derived glia can be used to identify critical cues that contribute to CNS disease progression and aid in investigation of therapeutic targets. [Display omitted] •Embryonic stem cell-derived glia cell types.•Protocols to generate glia in vitro.•Glial-derived cues playing roles in CNS disease progression.•Glial-derived CNS therapies.</description><identifier>ISSN: 0958-1669</identifier><identifier>ISSN: 1879-0429</identifier><identifier>EISSN: 1879-0429</identifier><identifier>DOI: 10.1016/j.copbio.2024.103131</identifier><identifier>PMID: 38599012</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Current opinion in biotechnology, 2024-06, Vol.87, p.103131, Article 103131</ispartof><rights>2024 Elsevier Ltd</rights><rights>Copyright © 2024 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-182fb866c148bf28f3704cbed9dfc68049507e652eef8aa188036587fda5c3d73</cites><orcidid>0000-0003-4832-5851 ; 0009-0000-1194-2464</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38599012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vardhan, Sangamithra</creatorcontrib><creatorcontrib>Jordan, Tyler</creatorcontrib><creatorcontrib>Sakiyama-Elbert, Shelly</creatorcontrib><title>Stem cell engineering approaches for investigating glial cues in central nervous system disorders</title><title>Current opinion in biotechnology</title><addtitle>Curr Opin Biotechnol</addtitle><description>Glial cells are important in maintaining homeostasis for neurons in the central nervous system (CNS). During CNS disease or after injury, glia react to altered microenvironments and often acquire altered functions that contribute to disease pathology. A major focus for research is utilizing stem cell (SC)-derived glia as a potential renewable source for cell replacement to restore function, including neuronal support, and as a model for disease states to identify therapeutic targets. In this review, we focus on SC differentiation protocols for deriving three types of glial cells, astrocytes, oligodendrocytes, and microglia. These SC-derived glia can be used to identify critical cues that contribute to CNS disease progression and aid in investigation of therapeutic targets. [Display omitted] •Embryonic stem cell-derived glia cell types.•Protocols to generate glia in vitro.•Glial-derived cues playing roles in CNS disease progression.•Glial-derived CNS therapies.</description><issn>0958-1669</issn><issn>1879-0429</issn><issn>1879-0429</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9UMtOwzAQtBCIlsIfIJQjlxQ7zsO-IKGKl1SJA3C2HHsdXCVOsdNK_XscpXDktNrdmd2ZQeia4CXBpLzbLFW_rW2_zHCWxxEllJygOWEVT3Ge8VM0x7xgKSlLPkMXIWwwxgWt8DmaUVZwjkk2R_J9gC5R0LYJuMY6AG9dk8jt1vdSfUFITO8T6_YQBtvIYVw2rZVtonZxaV3kusHH3oHf97uQhEMYT2obeq_Bh0t0ZmQb4OpYF-jz6fFj9ZKu355fVw_rVFFChpSwzNSsLBXJWW0yZqLSXNWguTaqZDjnBa6gLDIAw6QkjGFaFqwyWhaK6oou0O10Nyr_jtoG0dkwGpMOoi5BMa1odF3wCM0nqPJ9CB6M2HrbSX8QBIsxXLERU7hiDFdM4UbazfHDru5A_5F-04yA-wkA0efeghdBWXAKtPWgBqF7-_-HHzKjjj0</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Vardhan, Sangamithra</creator><creator>Jordan, Tyler</creator><creator>Sakiyama-Elbert, Shelly</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4832-5851</orcidid><orcidid>https://orcid.org/0009-0000-1194-2464</orcidid></search><sort><creationdate>20240601</creationdate><title>Stem cell engineering approaches for investigating glial cues in central nervous system disorders</title><author>Vardhan, Sangamithra ; Jordan, Tyler ; Sakiyama-Elbert, Shelly</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-182fb866c148bf28f3704cbed9dfc68049507e652eef8aa188036587fda5c3d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vardhan, Sangamithra</creatorcontrib><creatorcontrib>Jordan, Tyler</creatorcontrib><creatorcontrib>Sakiyama-Elbert, Shelly</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vardhan, Sangamithra</au><au>Jordan, Tyler</au><au>Sakiyama-Elbert, Shelly</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stem cell engineering approaches for investigating glial cues in central nervous system disorders</atitle><jtitle>Current opinion in biotechnology</jtitle><addtitle>Curr Opin Biotechnol</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>87</volume><spage>103131</spage><pages>103131-</pages><artnum>103131</artnum><issn>0958-1669</issn><issn>1879-0429</issn><eissn>1879-0429</eissn><abstract>Glial cells are important in maintaining homeostasis for neurons in the central nervous system (CNS). During CNS disease or after injury, glia react to altered microenvironments and often acquire altered functions that contribute to disease pathology. A major focus for research is utilizing stem cell (SC)-derived glia as a potential renewable source for cell replacement to restore function, including neuronal support, and as a model for disease states to identify therapeutic targets. In this review, we focus on SC differentiation protocols for deriving three types of glial cells, astrocytes, oligodendrocytes, and microglia. These SC-derived glia can be used to identify critical cues that contribute to CNS disease progression and aid in investigation of therapeutic targets. [Display omitted] •Embryonic stem cell-derived glia cell types.•Protocols to generate glia in vitro.•Glial-derived cues playing roles in CNS disease progression.•Glial-derived CNS therapies.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38599012</pmid><doi>10.1016/j.copbio.2024.103131</doi><orcidid>https://orcid.org/0000-0003-4832-5851</orcidid><orcidid>https://orcid.org/0009-0000-1194-2464</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0958-1669
ispartof Current opinion in biotechnology, 2024-06, Vol.87, p.103131, Article 103131
issn 0958-1669
1879-0429
1879-0429
language eng
recordid cdi_proquest_miscellaneous_3037399059
source Elsevier
title Stem cell engineering approaches for investigating glial cues in central nervous system disorders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A11%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stem%20cell%20engineering%20approaches%20for%20investigating%20glial%20cues%20in%20central%20nervous%20system%20disorders&rft.jtitle=Current%20opinion%20in%20biotechnology&rft.au=Vardhan,%20Sangamithra&rft.date=2024-06-01&rft.volume=87&rft.spage=103131&rft.pages=103131-&rft.artnum=103131&rft.issn=0958-1669&rft.eissn=1879-0429&rft_id=info:doi/10.1016/j.copbio.2024.103131&rft_dat=%3Cproquest_cross%3E3037399059%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c311t-182fb866c148bf28f3704cbed9dfc68049507e652eef8aa188036587fda5c3d73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3037399059&rft_id=info:pmid/38599012&rfr_iscdi=true